References
- Schmidt M, Bastians H. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. Drug Res 2007; 10: 162–181
- Lin I, Min Z, Ping Z. Expression of PLK1 and survivin in diffuse large B-cell lymphoma. Leuk Lymphoma 2007; 48: 2179–2183
- World health organisation classification of tumours. Pathology and genetics of hematopoietic and lymphoid tissues. E S Jaffe, N L Harris, H Stein, J W Vardinam. IARC, Lyon 2001
- Harris N L, Jaffe E S, Stein H, Banks P M, Chan J K, Cleary M L, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361–1392
- The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 1993; 329: 987–994
- Takai N, Hamanaka R, Yoshimatsu J, Miyakawa I. Polo-like kinases (PLKs) and cancer. Oncogene 2005; 24: 287–291